teprotide has been researched along with enalapril in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (93.75) | 18.7374 |
| 1990's | 2 (6.25) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loon, N; Meyer, T; Morelli, E; Myers, BD; Peters, W | 1 |
| Greenberg, B | 1 |
| Robertson, JI | 1 |
| Biollaz, J; Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Fouad, FM; Tarazi, RC | 1 |
| Arnolda, L; Cubela, R; Jackson, B; Johnston, CI; Larmour, I | 1 |
| Bendhack, LM; Lindsey, CJ; Paiva, AC | 1 |
| Franciosa, JA; Jordan, RA; Wilen, MM | 1 |
| Ferguson, RK; Riley, LJ; Vlasses, PH | 1 |
| Higa, T; Kida, O; Kodama, K; Kondo, K; Morotomi, Y; Someya, N; Tanaka, K | 1 |
| Anderson, S; Brenner, BM; Meyer, TW; Rennke, HG | 1 |
| Crozier, IG; Ikram, H; Lewis, GR; Nicholls, MG; Richards, AM; Webster, MW | 1 |
| Forgiarini, P; Gulati, N; Heusser, C; Hofbauer, KG; Wood, JM | 1 |
| Thind, GS | 1 |
| Koster, M | 1 |
| Nelson, EB; Pool, JL; Taylor, AA | 1 |
| Bauer, JH; Reams, GP | 1 |
| Gavras, H; Gavras, I | 1 |
| Irvin, JD; Viau, JM | 1 |
| Patchett, AA | 1 |
| Atlas, SA; Case, DB; Cody, RJ; Laragh, JH | 1 |
| Csicsmann, J; Hutchinson, JS; Mendelsohn, FA | 1 |
| Arbegast, PT; Blaine, EH; Gaul, SL; Gross, DM; Sweet, CS | 1 |
| Di Nicolantonio, R; Hutchinson, JS; Takata, Y | 1 |
| Ashworth, RW | 1 |
| Cody, RJ; Covit, AB; Laragh, JH; Schaer, GL | 1 |
| Blum, AM; Weinstock, JV | 1 |
| Arnolda, L; Cubela, R; Jackson, B; Johnston, CI | 1 |
| Cody, RJ | 1 |
| Lefer, AM; Peck, RC | 1 |
| Bauer, JH | 1 |
| Materson, BJ | 1 |
8 review(s) available for teprotide and enalapril
| Article | Year |
|---|---|
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperaldosteronism; Hypertension; Kinetics; Oligopeptides; Renin; Teprotide | 1985 |
Pharmacology of angiotensin converting enzyme inhibitors. A review.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Blood Pressure; Captopril; Eating; Enalapril; Half-Life; Humans; Intestinal Absorption; Kinetics; Oligopeptides; Peptidyl-Dipeptidase A; Renin; Teprotide | 1986 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
The chemistry of enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Binding Sites; Chemical Phenomena; Chemistry; Dipeptides; Enalapril; Enalaprilat; Humans; Molecular Conformation; Peptidyl-Dipeptidase A; Teprotide | 1984 |
Drugs affecting the renin-angiotensin system.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Humans; Renin; Renin-Angiotensin System; Teprotide | 1982 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
Topics: Body Fluids; Captopril; Dipeptides; Drug Evaluation; Enalapril; Glomerular Filtration Rate; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Potassium; Proline; Renin-Angiotensin System; Sodium; Teprotide | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
6 trial(s) available for teprotide and enalapril
| Article | Year |
|---|---|
Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Cell Membrane; Cell Membrane Permeability; Dextrans; Diabetic Nephropathies; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Male; Middle Aged; Oligopeptides; Proteins; Teprotide | 1990 |
Chronic treatment of hypertensive patients with converting enzyme inhibitors.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cerebrovascular Circulation; Clinical Trials as Topic; Coronary Circulation; Enalapril; Heart Rate; Humans; Hypertension; Lipids; Oligopeptides; Peptidyl-Dipeptidase A; Potassium; Rats; Rats, Inbred SHR; Renin; Sodium; Teprotide | 1986 |
Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure.
Topics: Adult; Aged; Body Weight; Dipeptides; Double-Blind Method; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oligopeptides; Physical Exertion; Renin; Teprotide | 1985 |
Clinical utility of angiotensin converting enzyme inhibitors in hypertension.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Creatinine; Enalapril; Humans; Hypertension; Oligopeptides; Teprotide | 1986 |
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Enalapril; Half-Life; Headache; Humans; Hypertension; Kidney Diseases; Neutropenia; Oligopeptides; Skin Diseases; Sulfhydryl Compounds; Taste Disorders; Teprotide | 1986 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
20 other study(ies) available for teprotide and enalapril
| Article | Year |
|---|---|
Enalapril maleate and teprotide.
Topics: Dosage Forms; Enalapril; Humans; Teprotide | 1991 |
Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Benzothiadiazines; Blood Pressure; Diuretics; Dogs; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Kidney; Oligopeptides; Rats; Renal Circulation; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Teprotide | 1986 |
Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Coronary Circulation; Enalapril; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension; Oligopeptides; Rats; Teprotide | 1986 |
Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Enalapril; Enalaprilat; Enzyme Inhibitors; Esterification; Humans; Hypertension; Kinetics; Liver; Oligopeptides; Peptidyl-Dipeptidase A; Teprotide | 1986 |
Effects of teprotide, captopril and enalaprilat on arterial wall kininase and angiotensin converting activity.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Captopril; Enalapril; Enalaprilat; Male; Mesenteric Arteries; Rats; Rats, Inbred Strains; Teprotide | 1987 |
Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Topics: 3-Mercaptopropionic Acid; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Enalapril; Female; Humans; Kallikreins; Kinins; Male; Middle Aged; Oligopeptides; Proline; Renin-Angiotensin System; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1985 |
Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency.
Topics: Animals; Enalapril; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney Failure, Chronic; Kidney Glomerulus; Male; Oligopeptides; Proteinuria; Rats; Rats, Inbred Strains; Teprotide | 1985 |
Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure.
Topics: Adult; Captopril; Diuresis; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Oligopeptides; Spironolactone; Teprotide | 1986 |
Monoclonal antibodies against human renin. Blood pressure effects in the marmoset.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Blood Pressure; Callithrix; Callitrichinae; Enalapril; Enalaprilat; Female; Male; Mice; Renin; Renin-Angiotensin System; Teprotide | 1986 |
Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
Topics: Acute Kidney Injury; Captopril; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Oligopeptides; Teprotide | 1985 |
[Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
Topics: Calcium Channel Blockers; Captopril; Drug Interactions; Enalapril; Humans; Hypertension; Nifedipine; Oligopeptides; Teprotide; Verapamil | 1986 |
Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Body Fluids; Captopril; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renal; Kidney; Oligopeptides; Proteinuria; Regional Blood Flow; Renin-Angiotensin System; Sodium Chloride; Teprotide | 1986 |
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Captopril; Enalapril; Enalaprilat; Heart Failure; Humans; Hypertension; Kinetics; Male; Nifedipine; Renin; Renin-Angiotensin System; Sodium; Teprotide; Vascular Resistance | 1983 |
Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dipeptides; Enalapril; Lung; Proline; Rats; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1981 |
Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
Topics: Angiotensin I; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Enalapril; Hypertension; Hypertension, Renal; Oligopeptides; Proline; Rats; Rats, Inbred Strains; Teprotide | 1981 |
A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dipeptides; Enalapril; Female; Oligopeptides; Proline; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Teprotide; Thiazolidines | 1982 |
Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chronic Disease; Dipeptides; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Hypotension, Orthostatic; Long-Term Care; Male; Middle Aged; Oligopeptides; Saralasin; Teprotide; Time Factors | 1983 |
Isolated liver granulomas of murine Schistosoma mansoni contain components of the angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Cell Migration Inhibition; Dipeptides; Enalapril; Endopeptidases; Female; Granuloma; Macrophages; Mice; Mice, Inbred CBA; Oligopeptides; Peptidyl-Dipeptidase A; Schistosoma mansoni; Schistosomiasis; Teprotide | 1983 |
Mechanism for hypotensive action of angiotensin converting enzyme inhibitors.
Topics: Antihypertensive Agents; Blood Pressure; Dipeptides; Enalapril; Enalaprilat; Enzyme Induction; Humans; Hypertension; Oligopeptides; Peptidyl-Dipeptidase A; Teprotide | 1984 |
Cardioprotective effects of enalapril in acute myocardial ischemia.
Topics: Acute Disease; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cats; Coronary Circulation; Coronary Disease; Creatine Kinase; Dipeptides; Electrocardiography; Enalapril; Male; Oligopeptides; Papillary Muscles; Teprotide | 1984 |